Literature DB >> 7002739

Treatment of distal ulcerative colitis (proctosigmoiditis) in relapse: comparison of hydrocortisone enemas and rectal hydrocortisone foam.

W S Ruddell, R J Dickinson, M F Dixon, A T Axon.   

Abstract

Thirty patients with distal colitis (proctosigmoiditis) in relapse were randonly allocated to twice daily treatment with traditional aqueous hydrocotrisone enemas (Cortenemas) or a suspension of hydrocortisone in an inert foam base (Colifoam). Each treatment contained the same amount of hydrocortisone. Clinical, sigmoidoscopic, and histological response was assessed after two weeks. Both agents were effective, and broadly similar in terms of objective improvement, but subjective improvement was greater with the foam preparation, and several patients expressed a preference to this mode of treatment.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7002739      PMCID: PMC1419374          DOI: 10.1136/gut.21.10.885

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  17 in total

1.  Treatment of ulcerative colitis with local hydrocortisone.

Authors:  S C TRUELOVE
Journal:  Br Med J       Date:  1956-12-01

2.  A local foam aerosol in ulcerative colitis.

Authors:  M L Clark
Journal:  Practitioner       Date:  1977-07

3.  Adjunctive use of a steroid rectal foam in the treatment of ulcerative colitis.

Authors:  N D Scherl; B A Scherl
Journal:  Dis Colon Rectum       Date:  1973 Mar-Apr       Impact factor: 4.585

4.  Treatment of ulcerative colitis with hydrocrotisone enemas: relationship of hydrocortisone absorption, adrenal suppression, and clinical response.

Authors:  R G Farmer; O P Schumacher
Journal:  Dis Colon Rectum       Date:  1970 Sep-Oct       Impact factor: 4.585

5.  Sensibility of the rectum to distension and the anorectal distension reflex in ulcerative colitis.

Authors:  M J Farthing; J E Lennard-jones
Journal:  Gut       Date:  1978-01       Impact factor: 23.059

6.  Clinical outcome of the first ten years of ulcerative colitis and proctitis.

Authors:  J K Ritchie; J Powell-Tuck; J E Lennard-Jones
Journal:  Lancet       Date:  1978-05-27       Impact factor: 79.321

7.  Retrograde spread of hydrocortisone containing foam given intrarectally in ulcerative colitis.

Authors:  M J Farthing; M D Rutland; M L Clark
Journal:  Br Med J       Date:  1979-10-06

8.  Plasma prednisolone levels and adrenocortical responsiveness after administration of prednisolone-21-phosphate as a retention enema.

Authors:  D A Lee; G M Taylor; V H James; G Walker
Journal:  Gut       Date:  1979-05       Impact factor: 23.059

9.  Plasma prednisolone levels after administration of prednisolone-21-phosphate as a retention enema in colitis.

Authors:  J Powell-Tuck; J E Lennard-Jones; C S May; C G Wilson; J W Paterson
Journal:  Br Med J       Date:  1976-01-24

10.  Colitis.

Authors:  S J Mallett; J E Lennard-Jones; J Bingley; E Gilon
Journal:  Lancet       Date:  1978-09-16       Impact factor: 79.321

View more
  20 in total

Review 1.  Histological healing in inflammatory bowel disease: a still unfulfilled promise.

Authors:  Vincenzo Villanacci; Elisabetta Antonelli; Karel Geboes; Giovanni Casella; Gabrio Bassotti
Journal:  World J Gastroenterol       Date:  2013-02-21       Impact factor: 5.742

Review 2.  A practical guide to the management of distal ulcerative colitis.

Authors:  S Ardizzone; G Bianchi Porro
Journal:  Drugs       Date:  1998-04       Impact factor: 9.546

3.  Effect of treatment on symptoms and quality of life in patients with ulcerative colitis: comparative trial of hydrocortisone acetate foam and prednisolone 21-phosphate enemas.

Authors:  K W Somerville; M J Langman; S P Kane; A J MacGilchrist; G Watkinson; P Salmon
Journal:  Br Med J (Clin Res Ed)       Date:  1985-09-28

Review 4.  Medical treatment of ulcerative colitis.

Authors:  J E Lennard-Jones
Journal:  Postgrad Med J       Date:  1984-11       Impact factor: 2.401

5.  Comparative study of enema retention and preference in ulcerative colitis.

Authors:  J R Ingram; J Rhodes; B K Evans; R G Newcombe; G A O Thomas
Journal:  Postgrad Med J       Date:  2005-09       Impact factor: 2.401

6.  Ulcerative colitis: an overview.

Authors:  A Archambault
Journal:  Can Fam Physician       Date:  1990-02       Impact factor: 3.275

Review 7.  Risk-benefit assessment of drugs used in the treatment of inflammatory bowel disease.

Authors:  S B Hanauer; G Stathopoulos
Journal:  Drug Saf       Date:  1991 May-Jun       Impact factor: 5.606

8.  Treatment of ulcerative colitis.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1981-04-18

9.  Better quality of therapy with 5-ASA colonic foam in active ulcerative colitis. A multicenter comparative trial with 5-ASA enema.

Authors:  M Campieri; P Paoluzi; G D'Albasio; G Brunetti; A Pera; L Barbara
Journal:  Dig Dis Sci       Date:  1993-10       Impact factor: 3.199

10.  Spread and distribution of 5-ASA colonic foam and 5-ASA enema in patients with ulcerative colitis.

Authors:  M Campieri; C Corbelli; P Gionchetti; C Brignola; A Belluzzi; G Di Febo; P Zagni; G Brunetti; M Miglioli; L Barbara
Journal:  Dig Dis Sci       Date:  1992-12       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.